{"disease":{"id":"pik3ca-gene-mutation","name":"pik3ca gene mutation"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04753203","title":"Alpelisib and Capecitabine in Patients With PIK3CA Mutant mCRC Patients","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":65,"lead_sponsor_name":"Korean Cancer Study Group","has_results":false},{"nct_id":"NCT04976439","title":"Patogenic Mutation in 5 Genes","phase":"","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"Dr Cipto Mangunkusumo General Hospital","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}